Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency.
Resino
Salvador
S
Bellón
Jose Ma
JM
Muñoz-Fernández
Ma Angeles
MA
D002648:Child; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000009:adverse effects* / Q000627:therapeutic use*; D019438:Ritonavir / Q000009:adverse effects* / Q000627:therapeutic use*; D016879:Salvage Therapy
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir